5-MeO-DiPT

5-MeO-DiPT (5-Methoxy-N,N-diisopropyltryptamine) is a psychedelic and hallucinogenic drug, used recreationally for its psychoactive effects. It is part of the tryptamine class of drugs, which also includes substances like psilocybin, found in magic mushrooms, and DMT.

History[edit]

5-MeO-DiPT was first synthesized in 1979 by the chemist Alexander Shulgin, who documented his findings in the book TiHKAL (Tryptamines I Have Known and Loved). The drug gained popularity in the late 1990s and early 2000s as a legal alternative to other psychedelic substances.

Pharmacology[edit]

5-MeO-DiPT acts primarily as a serotonin receptor agonist. It binds to and activates the receptor, leading to an increased release of serotonin in the brain. This increase in serotonin levels is thought to be responsible for the drug's psychedelic effects.

Effects[edit]

The effects of 5-MeO-DiPT are similar to those of other tryptamines and can include visual and auditory hallucinations, altered perception of time, enhanced introspection, and increased emotional sensitivity. However, 5-MeO-DiPT is also known for its unique entactogenic effects, which can include feelings of empathy and emotional openness.

Legal Status[edit]

The legal status of 5-MeO-DiPT varies by country. In the United States, it is classified as a Schedule I drug under the Controlled Substances Act, meaning it is illegal to manufacture, distribute, or possess. In the United Kingdom, it is classified as a Class A drug under the Misuse of Drugs Act.

See Also[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!

Navigation-> Medicine - Wellness - Encyclopedia - Health topics - Diseases - Drugs - Gray's Anatomy - W8MD diet - Ketogenic diet - Recipes

Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Translate page: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian